Literature DB >> 16452402

The global regulatory proteins LetA and RpoS control phospholipase A, lysophospholipase A, acyltransferase, and other hydrolytic activities of Legionella pneumophila JR32.

Markus Broich1, Kerstin Rydzewski, Tamara L McNealy, Reinhard Marre, Antje Flieger.   

Abstract

Legionella pneumophila possesses a variety of secreted and cell-associated hydrolytic activities that could be involved in pathogenesis. The activities include phospholipase A, lysophospholipase A, glycerophospholipid:cholesterol acyltransferase, lipase, protease, phosphatase, RNase, and p-nitrophenylphosphorylcholine (p-NPPC) hydrolase. Up to now, there have been no data available on the regulation of the enzymes in L. pneumophila and no data at all concerning the regulation of bacterial phospholipases A. Therefore, we used L. pneumophila mutants in the genes coding for the global regulatory proteins RpoS and LetA to investigate the dependency of hydrolytic activities on a global regulatory network proposed to control important virulence traits in L. pneumophila. Our results show that both L. pneumophila rpoS and letA mutants exhibit on the one hand a dramatic reduction of secreted phospholipase A and glycerophospholipid:cholesterol acyltransferase activities, while on the other hand secreted lysophospholipase A and lipase activities were significantly increased during late logarithmic growth phase. The cell-associated phospholipase A, lysophospholipase A, and p-NPPC hydrolase activities, as well as the secreted protease, phosphatase, and p-NPPC hydrolase activities were significantly decreased in both of the mutant strains. Only cell-associated phosphatase activity was slightly increased. In contrast, RNase activity was not affected. The expression of plaC, coding for a secreted acyltransferase, phospholipase A, and lysophospholipase A, was found to be regulated by LetA and RpoS. In conclusion, our results show that RpoS and LetA affect phospholipase A, lysophospholipase A, acyltransferase, and other hydrolytic activities of L. pneumophila in a similar way, thereby corroborating the existence of the LetA/RpoS regulation cascade.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16452402      PMCID: PMC1367211          DOI: 10.1128/JB.188.4.1218-1226.2006

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  68 in total

1.  A two-component regulator induces the transmission phenotype of stationary-phase Legionella pneumophila.

Authors:  Brian K Hammer; Eiko S Tateda; Michele S Swanson
Journal:  Mol Microbiol       Date:  2002-04       Impact factor: 3.501

2.  Novel transcriptional regulators of Legionella pneumophila that affect replication in Acanthamoeba castellanii.

Authors:  Ilya Lebeau; Elke Lammertyn; Emmy De Buck; Liesbeth Maes; Nick Geukens; Lieve Van Mellaert; Jozef Anné
Journal:  Arch Microbiol       Date:  2004-03-19       Impact factor: 2.552

3.  Genetic evidence that Legionella pneumophila RpoS modulates expression of the transmission phenotype in both the exponential phase and the stationary phase.

Authors:  Michael A Bachman; Michele S Swanson
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

4.  Detection of a gene encoding a phosphatidylinositol-specific phospholipase C that is co-ordinately expressed with listeriolysin in Listeria monocytogenes.

Authors:  M Leimeister-Wächter; E Domann; T Chakraborty
Journal:  Mol Microbiol       Date:  1991-02       Impact factor: 3.501

5.  ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury.

Authors:  V Finck-Barbançon; J Goranson; L Zhu; T Sawa; J P Wiener-Kronish; S M Fleiszig; C Wu; L Mende-Mueller; D W Frank
Journal:  Mol Microbiol       Date:  1997-08       Impact factor: 3.501

6.  The phagosome containing Legionella pneumophila within the protozoan Hartmannella vermiformis is surrounded by the rough endoplasmic reticulum.

Authors:  Y Abu Kwaik
Journal:  Appl Environ Microbiol       Date:  1996-06       Impact factor: 4.792

7.  Intracellular growth of Legionella pneumophila gives rise to a differentiated form dissimilar to stationary-phase forms.

Authors:  Rafael A Garduño; Elizabeth Garduño; Margot Hiltz; Paul S Hoffman
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

8.  RpoS is not central to the general stress response in Borrelia burgdorferi but does control expression of one or more essential virulence determinants.

Authors:  Melissa J Caimano; Christian H Eggers; Karsten R O Hazlett; Justin D Radolf
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

9.  The two-component regulators GacS and GacA influence accumulation of the stationary-phase sigma factor sigmaS and the stress response in Pseudomonas fluorescens Pf-5.

Authors:  C A Whistler; N A Corbell; A Sarniguet; W Ream; J E Loper
Journal:  J Bacteriol       Date:  1998-12       Impact factor: 3.490

10.  The mechanism of action of the Pseudomonas aeruginosa-encoded type III cytotoxin, ExoU.

Authors:  Hiromi Sato; Dara W Frank; Cecilia J Hillard; Jimmy B Feix; Ravi R Pankhaniya; Kiyoshi Moriyama; Viviane Finck-Barbançon; Adam Buchaklian; Ming Lei; Roy M Long; Jeanine Wiener-Kronish; Teiji Sawa
Journal:  EMBO J       Date:  2003-06-16       Impact factor: 11.598

View more
  13 in total

1.  SigmaS controls multiple pathways associated with intracellular multiplication of Legionella pneumophila.

Authors:  Galadriel Hovel-Miner; Sergey Pampou; Sebastien P Faucher; Margaret Clarke; Irina Morozova; Pavel Morozov; James J Russo; Howard A Shuman; Sergey Kalachikov
Journal:  J Bacteriol       Date:  2009-02-13       Impact factor: 3.490

Review 2.  Role of RpoS in virulence of pathogens.

Authors:  Tao Dong; Herb E Schellhorn
Journal:  Infect Immun       Date:  2009-11-30       Impact factor: 3.441

3.  Type II Secretion Is Necessary for Optimal Association of the Legionella-Containing Vacuole with Macrophage Rab1B but Enhances Intracellular Replication Mainly by Rab1B-Independent Mechanisms.

Authors:  Richard C White; Nicholas P Cianciotto
Journal:  Infect Immun       Date:  2016-11-18       Impact factor: 3.441

4.  Legionella pneumophila Cas2 Promotes the Expression of Small Heat Shock Protein C2 That Is Required for Thermal Tolerance and Optimal Intracellular Infection.

Authors:  Jackson A Campbell; Nicholas P Cianciotto
Journal:  Infect Immun       Date:  2022-09-08       Impact factor: 3.609

5.  The Legionella pneumophila Dot/Icm-secreted effector PlcC/CegC1 together with PlcA and PlcB promotes virulence and belongs to a novel zinc metallophospholipase C family present in bacteria and fungi.

Authors:  Philipp Aurass; Maren Schlegel; Omar Metwally; Clare R Harding; Gunnar N Schroeder; Gad Frankel; Antje Flieger
Journal:  J Biol Chem       Date:  2013-03-01       Impact factor: 5.157

6.  Lgt: a family of cytotoxic glucosyltransferases produced by Legionella pneumophila.

Authors:  Yury Belyi; Irina Tabakova; Michael Stahl; Klaus Aktories
Journal:  J Bacteriol       Date:  2008-02-15       Impact factor: 3.490

7.  Nicotinic acid modulates Legionella pneumophila gene expression and induces virulence traits.

Authors:  Rachel L Edwards; Andrew Bryan; Matthieu Jules; Kaoru Harada; Carmen Buchrieser; Michele S Swanson
Journal:  Infect Immun       Date:  2013-01-14       Impact factor: 3.441

8.  Zinc metalloproteinase ProA directly activates Legionella pneumophila PlaC glycerophospholipid:cholesterol acyltransferase.

Authors:  Christina Lang; Elena Rastew; Björn Hermes; Enrico Siegbrecht; Robert Ahrends; Sangeeta Banerji; Antje Flieger
Journal:  J Biol Chem       Date:  2012-05-11       Impact factor: 5.157

Review 9.  The many forms of a pleomorphic bacterial pathogen-the developmental network of Legionella pneumophila.

Authors:  Peter Robertson; Hany Abdelhady; Rafael A Garduño
Journal:  Front Microbiol       Date:  2014-12-22       Impact factor: 5.640

10.  The CRISPR-associated gene cas2 of Legionella pneumophila is required for intracellular infection of amoebae.

Authors:  Felizza F Gunderson; Nicholas P Cianciotto
Journal:  MBio       Date:  2013-03-12       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.